Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy

Most algorithms for type 2 diabetes mellitus (T2DM) do not recommend treatment escalation until glycated haemoglobin (HbA1c) fails to reach the recommended target of 7% (53 mmol/mol) within approximately 3 months on any treatment regimen (“treat to failure”). Clinical inertia and/or poor adherence t...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, David R., Monnier, Louis, Barnett, Anthony H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637910/
https://www.ncbi.nlm.nih.gov/pubmed/28432748
http://dx.doi.org/10.1111/dom.12977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637910/
https://www.ncbi.nlm.nih.gov/pubmed/28432748
http://dx.doi.org/10.1111/dom.12977

Ejemplares similares